ALRPD.PA: Rebalance upward – €1…!
>Trading Call. We are maintaining our BUY on Rapid Nutrition PLC (ALRPD.PA), however, we are adjusting our risk rating to HIGH from SPECULATIVE. Our price objective of €1.00 per share is unchanged. Month-to-date, the shares are up by 68%, outperforming the peer group that is down by 2% and the Euronext 100 that is up by 1.9%, respectively. We recommend accumulate the shares on weakness.>Rebalance Upward. Following the termination of the second tranche of the Atlas convertible loan, the company strategic review of the growth outlook in 2024 beyond, the entrance in China, has led the company to expedite repayment of approximately €570.1K. This is more than half of the outstanding convertible loan. The remainder of the convertible loan is expected to be paid by year-end. With this in mind, we believe that it’s worthwhile to rebalance our risk rating to HIGH from SPECULATIVE.
>Asia Pacific Region. We believe the recent foray into Japan and Korea should continue to boost the company’s footprint in the Asia-Pacific region. In our view, this presents plenty of opportunities for the company to capture market share of the $10-15 billion wellness market in the coming years. We see this yielding a positive reaction for Azurene and the SystemLS brand from wellness consumers and equating to an increase in shareholder return.
>We continue to believe that management’s strong commitment to plant-based technology should continue to strengthen revenues in 2024 and beyond, enhancing Rapid Nutrition PLC’s brand value.
>Take Advantage of Volatility. We expect the market to be volatile as we get closer towards the end of the third quarter and we see any pullback as an opportunity to accumulate the shares. We are maintaining our BUY HIGH RISK and our price objective of €1.00 per share.
The Zephirin Group, Inc. is widely recognized as a World Leading Independent Investment Research Company. The Wall Street Journal, Financial Times/StarMine and FactSet Research have recognized The Zephirin Group as an industry leader – naming us as one of the World's Top Analysts based on high performance and accuracy for earnings and stock picking. The Zephirin Group is a celebrated and award-winning Independent Investment Research Company and has been listed in the Top 5 Star Analyst List for all years 2008 to 2021 YTD. The firm offers equity research, fixed income research, corporate finance, quantitative research, and index research to financial services firms; business research, company profile, and industry studies to business services firms; and data analytics, index analytics, risk analytics, benchmark analytics, financial analysis, model development, and valuation modeling to data services firms. It offers research on small, mid and large capitalized under-valued and under-covered global-listed equities. The firm provides institutional research and sponsored research services. It offers pre-IPO services and reports, boutique services including merger and acquisition advisory, equity and debt raising advisory and energy and real estate advisory services. The firm offers fundamental research with a combination of top down and bottom up research. It also provides consulting on listing issues, compliance, corporate governance, and investor communication services. The Zephirin Group, Inc. is based in New York with satellite office in Hong Kong and Shenzhen.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.